---
title: "SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum | SPRC Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287920812.md"
description: "SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum | SPRC Stock News"
datetime: "2026-05-28T04:40:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287920812.md)
  - [en](https://longbridge.com/en/news/287920812.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287920812.md)
---

# SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum | SPRC Stock News

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum | SPRC Stock News

### Related Stocks

- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)
- [Biotech experts want FDA drug reviews based on science, not politics](https://longbridge.com/en/news/293453841.md)
- [Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US](https://longbridge.com/en/news/293415324.md)
- [President sets import tariffs after 2-year grace period for medicines](https://longbridge.com/en/news/293409053.md)
- [SPARC AI Says No Material Change Behind Trading Surge, Flags Elevated Risks](https://longbridge.com/en/news/279479729.md)